A network of clinical trial centres will launch in the UK to improve survival rates among patients suffering from blood cancers, the most common cause of cancer deaths in the under-35s.

Blood cancer charity Leukaemia and Lymphoma Research is linking 13 UK research centres in the hope to speed up development of new drug treatments.

There are also difficulties in establishing clinical trials because of problems recruiting enough patients at a single hospital to make them viable. Some trials have run as long as ten years before usable results have been obtained.

The charity will receive financial help from pharmaceutical companies and NHS hospitals in a bid to see trials completed within two years, bringing £50m worth of promising new medications to market.

The charity’s clinical trials adviser, Professor Charlie Craddock, told the BBC, “We have a moral case for getting new drugs out there as soon as possible. If you have a relative with a blood cancer, you don’t want life-saving treatment available in ten years. You want it now.”